Asia Preimplantation Genetic Diagnosis Market to Reach US$28.8 Mn by 2023, Propelled by Increasing Occurrence of Congenital Heart Diseases
The usage of preimplantation genetic diagnosis (PGD) to screen genetic diseases and embryos for aneuploidy is increasing considerably. PGD benefits people at the risk of passing on a particular genetic disease to the next generation. PGD tests can be done for almost hundred different genetic diseases or conditions. The growing applications of PGD are expected to propel the Asia preimplantation genetic diagnosis market in the years to come. Over the past few years, there has been an increase in the...
View full press release